FCGR2B and systemic lupus erythematosus: One study has reported a decrease in expression of FcγRIIb on B cells in active systemic lupus erythematosus (SLE) patients as compared to healthy control, suggesting its protective role in SLE (Ochi and Kawabi, 1992).